Cellnovo Limited is a medical technology company that specializes in diabetes management solutions. The company's innovative insulin pump system includes a mobile-connected device for glucose monitoring and insulin delivery. With a focus on improving patient outcomes and quality of life, Cellnovo is committed to advancing the field of diabetes care through cutting-edge technology and personalized support.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#3 in Swansea

#2,100 in United Kingdom

Swansea, United Kingdom

Cellnovo Limited

Forward Citations = 64

7 inventors:

Julian Llewellyn Shapley (8 out of 12 patents)

Matthew Powell (5 out of 9 patents)

Joseph John Cefai (5 out of 18 patents)

4. Mark Jones (2 out of 6 patents)

5. Neil Thomas (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cellnovo Limited. Retrieved from https://idiyas.com/company/cellnovo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]